Hybrid bivalent ligands with opiate and enkephalin pharmacophores

Journal of Medicinal Chemistry
1987.0

Abstract

Bivalent ligands consisting of oxymorphamine and [D-Glu2]enkephalin pharmacophores linked through a spacer attached to the 6-amino group of the former and D-Glu of the latter were synthesized in an effort to investigate the possible coexistence of mu and delta recognition sites in the same opioid receptor complex. Of the two bivalent ligands (1,2) synthesized, only 1 had substantially greater antinociceptive potency in mice than its monovalent analogues (1a, 1b). Testing of 1, 1a, and 1b in the guinea pig ileum preparation (GPI) revealed a potency profile similar to that found in vivo, whereas no correlation was observed in the mouse vas deferens (MVD). Binding data indicated the same rank-order affinities at delta receptors as the opioid activities in the GPI and in mice. However, mu binding exhibited no relationship with activity. These results are consistent with the simultaneous occupation of mu and delta by a single bivalent ligand 1, but they are also in harmony with the interaction of 1 with an opioid receptor and an accessory binding site.

Knowledge Graph

Similar Paper

Hybrid bivalent ligands with opiate and enkephalin pharmacophores
Journal of Medicinal Chemistry 1987.0
Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors
Journal of Medicinal Chemistry 2007.0
Synthesis and Preliminary In vitro Investigation of Bivalent Ligands Containing Homo- and Heterodimeric Pharmacophores at μ, δ, and κ Opioid Receptors
Journal of Medicinal Chemistry 2006.0
Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors
European Journal of Medicinal Chemistry 2019.0
Synthesis and Biological Activities of Cyclic Lanthionine Enkephalin Analogues:  δ-Opioid Receptor Selective Ligands
Journal of Medicinal Chemistry 2002.0
Design, synthesis and biological evaluation of a bivalent μ opiate and adenosine A1 receptor antagonist
Bioorganic & Medicinal Chemistry Letters 2009.0
Novel Bivalent Ligands for D2/D3 Dopamine Receptors: Significant Cooperative Gain in D2 Affinity and Potency
ACS Medicinal Chemistry Letters 2012.0
Identification of Opioid Ligands Possessing Mixed μ Agonist/δ Antagonist Activity among Pyridomorphinans Derived from Naloxone, Oxymorphone, and Hydropmorphone
Journal of Medicinal Chemistry 2004.0
Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors
Bioorganic & Medicinal Chemistry 2011.0
Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain
Bioorganic & Medicinal Chemistry 2009.0